ciprofloxacin "pharmathen" 500 mg filmovertrukne tabletter
pharmathen s.a. - ciprofloxacinhydrochlorid (monohydrat) - filmovertrukne tabletter - 500 mg
ciprofloxacin "pharmathen" 750 mg filmovertrukne tabletter
pharmathen s.a. - ciprofloxacinhydrochlorid (monohydrat) - filmovertrukne tabletter - 750 mg
lanreotid "pharmathen" 120 mg injektionsvæske, opløsning i fyldt injektionssprøjte
pharmathen s.a. - lanreotidacetat - injektionsvæske, opløsning i fyldt injektionssprøjte - 120 mg
lanreotid "pharmathen" 90 mg injektionsvæske, opløsning i fyldt injektionssprøjte
pharmathen s.a. - lanreotidacetat - injektionsvæske, opløsning i fyldt injektionssprøjte - 90 mg
deferasirox "pharmathen" 180 mg filmovertrukne tabletter
pharmathen s.a. - deferasirox - filmovertrukne tabletter - 180 mg
deferasirox "pharmathen" 360 mg filmovertrukne tabletter
pharmathen s.a. - deferasirox - filmovertrukne tabletter - 360 mg
leflunomid "pharmathen" 15 mg filmovertrukne tabletter
pharmathen s.a. - leflunomid - filmovertrukne tabletter - 15 mg
leflunomid "pharmathen" 20 mg filmovertrukne tabletter
pharmathen s.a. - leflunomid - filmovertrukne tabletter - 20 mg
dimethylfumarat "pharmathen" 240 mg enterokapsler, hårde
pharmathen s.a. - dimethylfumarat - enterokapsler, hårde - 240 mg
iasibon
pharmathen s.a. - ibandronsyre - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - narkotika til behandling af knoglesygdomme - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. behandling af tumor-induceret hypercalcaemia med eller uden metastaser. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.